Obesity Drugs: A Missed Opportunity In England For Outcomes And Spending?

 
• By Francesca Bruce
  
The poorly planned roll out of obesity drugs through England's NHS means that patients may not see the hoped for health outcomes. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from United Kingdom